A1LN34:BVMF
Alnylam Pharmaceuticals Inc Bdr
59,84 R$
0,00%
(0,00) 1D
16 ოქტ, 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1LN34...
Open
59,28 R$
High
59,84 R$
Low
59,28 R$
Mkt. cap
31,02 მლრდ.
Avg. vol.
446,00
Volume
17,00
52-wk high
131,80 R$
52-wk low
50,25 R$
Shares outstanding
133,81 მლნ.
No. of employees
2 ათ.
Open
59,28 R$
High
59,84 R$
Low
59,28 R$
Mkt. cap
31,02 მლრდ.
Avg. vol.
446,00
Volume
17,00
52-wk high
131,80 R$
52-wk low
50,25 R$
Shares outstanding
133,81 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
·
9 საათის წინ
BofA cuts target to USD 336.00 for Alnylam Pharmaceuticals stock
ad-hoc-news.de
·
2 დღის წინ
Citigroup cuts target to USD 320 for Alnylam Pharmaceuticals stock
Profile
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals Inc Bdr